Attending RDD ASIA 2024? Meet our team in Kerala, during the conference to discuss all aspects of pulmonary and nasal drug delivery development challenges

The RDD ASIA 2024 Conference will take place Nov 19-21, 2024, Kerala, India. Get in touch with our team to discuss your OINDP development challenges during the event.

RDD ASIA 2024 Workshop on Generic Nasal Suspensions
In-Vitro Only Bioequivalence Pathways for Generic Nasal Suspensions - The Challenge and the Opportunity

Delivered by Ben Stafford, Senior Analyst, and Paul Martin, Associate Director, Business Development, this workshop covers robust testing package design using traditional in vitro spray characterization tests for generic product submissions (SAC, DPS, SP, DISP, DSD, PG, Priming/Re-priming). It also includes practical tips for overcoming challenges presented by complex techniques, such as Morphologically Directed Raman Spectroscopy (MDRS) and dissolution.

Why should you attend?
Participants can expect to gain a thorough understanding of how to design and execute MDRS and dissolution studies for nasal suspension products, and how these fit more widely into formal IV-BE packages for generic submissions.

Questions? Get in touch: bd.melbourn@intertek.com
Not attending RDD ASIA 2024? You can request the workshop here.

Learn more about Intertek:
During RDD ASIA 2024, connect with our team in person to discuss all aspects of OINDP development, such as in vitro testing approaches, optimising formulation development for systemic delivery, nasal drug development, and more. Our experts will also provide updates on the commissioning of our new 20,000 sq.ft facility for the development of biologics for respiratory delivery.

Our integrated formulation and analytical teams carry out early stage pre-formulation support, solubility screening, drug-excipient compatibility, stability testing, device screening and clinical manufacturing services for all types of respiratory products. Comprehensive protein characterisation services, aligned to monitoring a protein’s structure and potency throughout formulation and storage, can also be provided.

Learn more about our RDD Europe 2023 Workshop

RDD 2023 WORKSHOP:
How To Build An Inhaler – Navigating New Technologies For Inhaled Product Development To Meet The Ever Expanding Challenges Of Both Small And Large Molecules.

 

INTERTEK RESOURCES 
ARTICLE DOWNLOAD | Nebulised Drug Development Considerations 
ARTICLE DOWNLOAD | In Vitro Bio-equivalence For OINDP - Where are we now? 
ARTICLE DOWNLOAD |  Overcoming the Challenges of Inhaled Biologic Drug Development 
WEBINAR ON DEMAND | Formulation and Manufacturing Approaches for Nasal Drug Products 
WEBINAR ON DEMAND |  Review of In-vitro Testing for Bioequivalence of Nasal Drug Products 
BROCHURE | Intertek Inhaled Product Development Services 
BROCHURE | Inhaled Biologic Drug Development Services

 

Need help or have a question?

Related Links

Intertek Melbourn Laboratory

GMP Pharmaceutical Analysis and Formulation Expertise

Intertek Melbourn
Saxon Way, Melbourn
Herts, SG8 6DN 
UK

RECENT NEWS: Intertek partners with CrystecPharma to advance formulation science and accelerate development for dry powder inhalers

Contact Intertek